Skip to main navigation menu Skip to main content Skip to site footer

Rate of positivity of Covid-19 testing in Colombia

Positividad y proporción para muestras por COVID-19 en Colombia




Section
Research Article

How to Cite
Díaz Pinzón, J. E. (2020). Rate of positivity of Covid-19 testing in Colombia. Journal of Medicine and Surgery Repertoire, 127-130. https://doi.org/10.31260/RepertMedCir.01217372.1134

Dimensions
PlumX
Citations
license

   

Jorge Enrique Díaz Pinzón

    Jorge Enrique Díaz Pinzón,

    Ingeniero. Magister en Gestión de la Tecnología Educativa, Especialista en Administración de la Informática Educativa. Docente de matemáticas e Investigador.


    Introduction: since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, on December 2019, the coronavirus 2019 (COVID-19) disease has been spreading worldwide. This disease is caused by a novel coronavirus, the severe acute respiratory syndrome coronavirus 2. Objective: to describe the positive rate of SARS-CoV-2 testing. Methodology: this research focused in PCR processing for COVID-19, using the information collected by the National Institute of Health, over the period between March 6 and October 31 2020. Results: we evidenced that the day in which the greatest number of samples were taken was 24-07-2020, with 41.550, followed by 40.034 samples taken on 23-07-2020, and 39.228 on 22-07-2020. The highest number of tests returning a positive result was reported on 21-07-2020 with 12.160, followed by 11.983 on 23-07-2020, and 11.879 on 29-07-2020. Likewise, the highest positive rate of 0.33 was evidenced on 19-07-2020, followed by 0.32 on 09-08-2020 and 0.31 on 30-08-2020. Conclusion: we must continue on the active search to identify infected people through conducting more PCR, and viral and molecular antigen tests, the latter offering a high level of accuracy, at the healthcare facilities (EPSs), which accelerate timely reporting to people.


    Article visits 2011 | PDF visits 875


    Downloads

    Download data is not yet available.
    1. Rubín, R. The Challenges of Expanding Rapid Tests to Curb COVID-19. JAMA. 2020;324(18):1813-1815. doi: 10.1001/jama.2020.21106 DOI: https://doi.org/10.1001/jama.2020.21106
    2. Center for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 (COVID-19) [Internet]. 2020 [Citado novirmbre] Recuperado de: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
    3. West CP, Montori VM, Sampathkumar P. COVID-19 Testing: The Threat of False-Negative Results. 2020;95(6):1127-1129. doi: 10.1016/j.mayocp.2020.04.004 DOI: https://doi.org/10.1016/j.mayocp.2020.04.004
    4. Yelin I, Aharony N, Shaer Tamar E, Argoetti A, et al. Evaluation of COVID-19 RT-qPCR test in multi-sample pools. Clin Infect Dis. 2020;ciaa531. doi: 10.1093/cid/ciaa531 DOI: https://doi.org/10.1101/2020.03.26.20039438
    5. Organización Mundial de la Salud. Enfermedad por coronavirus (COVID-19): informe de situación 110 [Internet]. 2020 [citado noviembre 9]; Recuperado en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200509covid-19- sitrep-110.pdf? sfvrsn = 3b92992c_4
    6. Joost, W. Hallie, P. What Is COVID-19?. JAMA. 2020;324(8):816. doi: 10.1001/jama.2020.12984 doi: 10.1001 / jama.2020.12984. DOI: https://doi.org/10.1001/jama.2020.12984
    7. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-793. doi: 10.1001/jama.2020.12839 DOI: https://doi.org/10.1001/jama.2020.12839
    8. Huynh PP, Ishii LE, Ishii M. What Is Anosmia?. JAMA. 2020;324(2):206. doi: 10.1001/jama.2020.109669. DOI: https://doi.org/10.1001/jama.2020.10966
    9. Ahmed H, Patel K, Greenwood D, et al. Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalisation or icu admission: a systematic review and meta-analysis of follow-up studies. medRxiv. 2020. doi: 10.1101 / 2020.04.16.20067975 DOI: https://doi.org/10.1101/2020.04.16.20067975
    10. Organización Panamericana de la Salud. COVID-19 y comorbilidades – AMÉRICAS: Herramienta práctica para estimar la población con mayor riesgo y riesgo alto de enfermedad grave por COVID-19 debido a condiciones de salud subyacentes en las Américas [Internet]. 2020 [citado noviembre 9]; Disponible en: https://www.paho.org/es/documentos/covid-19-comorbilidades-americas-antecedentes
    11. Bilinski A, Mostashari F, Salomon JA. Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures. JAMA Netw Open. 2020;3(8):e2019217. doi: 10.1001/jamanetworkopen.2020.19217 DOI: https://doi.org/10.1001/jamanetworkopen.2020.19217
    12. Díaz-Pinzón, J.E. Simulador Applet Descartes: como didáctica de enseñanza de la función cuadrática. INNOVA Research Jornal. 2017;2(8):69-78. doi: 10.33890/innova.v2.n8.2017.256 DOI: https://doi.org/10.33890/innova.v2.n8.2017.256
    13. Instituto Nacional de Salud. Coronavirus (COVID-2019) en Colombia [Internet]. Bogotá: Instituto Nacional de Salud; 2020 [citado 2020 octubre 28]. Recuperado de: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx.
    14. Díaz-Pinzón JE. Precisión del pronóstico de la propagación del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):27-33. doi: 10.31260/RepertMedCir.01217372.1045 DOI: https://doi.org/10.31260/RepertMedCir.01217372.1045
    Sistema OJS 3.4.0.5 - Metabiblioteca |